Mithril is a global technology investment firm investing in the technology, macroeconomics and finance sectors.
Business Model: B2B
Revenue: $1.7M
Employees: 2-10
Address: 600 Congress Ave.
City: Austin
State: TX
Zip: 78701
Country: US
Mithril is a family of long-term venture capital funds agnostic to sector and geography. They provide capital to leading growth companies by partnering with teams who use technology to build transformative and durable businesses.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
8/2014 | Helion Energy | Seed Round | 1.5M |
9/2014 | Fractyl Health | Series B | 19.8M |
8/2014 | MagForce | Post-IPO Equity | 15M |
12/2020 | Paxos | Series C | 0 |
6/2015 | Classy | Series B | 0 |
6/2016 | Spaceflight Industries | Series B | 25M |
9/2014 | Partnerize | Series B | 10M |
10/2022 | Neocis | Series D | 0 |
10/2020 | Neocis | Series D | 72M |
6/2017 | Avitide | Equity | 12M |
7/2013 | C2FO | Series C | 0 |
8/2014 | DoubleDutch | Series D | 15M |
11/2020 | Adagio Therapeutics | Series B | 0 |
8/2014 | Lookout | Series F | 150M |
10/2022 | Genetesis | Series C | 0 |
9/2020 | Nuvia | Series B | 240M |
1/2016 | Helion Energy | Series B | 21.3M |
11/2021 | Helion Energy | Series E | 0 |
10/2015 | AppDirect | Series E | 0 |
7/2020 | Adagio Therapeutics | Series A | 0 |
4/2021 | Paxos | Series D | 0 |
10/2022 | Juno | Series A | 0 |
11/2016 | Classy | Series C | 0 |
11/2021 | Ankyra | Series B | 45M |
9/2018 | GreyOrange | Series C | 140M |
4/2021 | Adagio Therapeutics | Series C | 0 |
6/2018 | Capture2 | Series A | 4M |
5/2018 | Figure | Series A | 50M |
5/2022 | GreyOrange | Venture Round | 0 |
9/2019 | Glance | Venture Round | 45M |
8/2020 | Fractyl Health | Series E | 0 |
2/2015 | AppDirect | Series D | 50M |
11/2017 | Fractyl Health | Series D | 0 |
3/2022 | AiFi | Series B | 0 |
4/2018 | Ment.io | Venture Round | 6M |
5/2022 | GreyOrange | Debt Financing | - |
9/2016 | Avitide | Series D | - |
8/2022 | Fractyl Health | Series F | - |
6/2016 | Partnerize | Series C | 15.4M |
10/2013 | Lookout | Series E | 55M |
6/2022 | Oma Fertility | Venture Round | 0 |
3/2021 | ForSight Robotics | Seed Round | 10M |
3/2021 | Flex Logix Technologies | Series D | 55M |
6/2021 | Generation Home | Series A | 0 |
7/2022 | ForSight Robotics | Series A | 0 |
8/2017 | Auris Health | Series D | 0 |
9/2020 | Treasure Financial | Seed Round | 0 |
11/2018 | Auris Health | Series E | 0 |
4/2014 | AppDirect | Series C | 35M |
9/2015 | Auris Health | Series B | 149.5M |
3/2014 | Auris Health | Series A | 34.4M |
7/2019 | Neocis | Venture Round | 30M |
11/2015 | Fractyl Health | Series C | 57M |
5/2016 | Stem | Series C | 15M |
9/2021 | BlackSky Global | Post-IPO Equity | 180M |
9/2014 | Palantir Technologies | Series I | 444.2M |
2/2018 | C2FO | Series F | 100M |
12/2020 | Glance | Venture Round | 145M |
8/2015 | C2FO | Series E | 0 |
4/2014 | SilverRail Technologies | Series C | 40M |
7/2022 | ForSight Robotics | Series A | 0 |
6/2022 | Oma Fertility | Venture Round | 0 |
5/2022 | GreyOrange | Debt Financing | - |
5/2022 | GreyOrange | Venture Round | 0 |
3/2022 | AiFi | Series B | 0 |
11/2021 | Ankyra | Series B | 0 |
11/2021 | Helion Energy | Series E | 0 |
9/2021 | BlackSky Global | Post-IPO Equity | 0 |
6/2021 | Generation Home | Series A | 0 |
4/2021 | Paxos | Series D | 0 |
Name | Price |
---|
Name | Size | Announced Date |
---|